Evidence map›Paper›PMID 36529517›Full record

ArticleThe Journal of reproduction and development2023

Removal of sperm tail using trypsin and pre-activation of oocyte facilitates intracytoplasmic sperm injection in mice and rats.

Kohei Torikai, Kazuma Shimizu, Hiroaki Nagatomo, Mariko Kasai, Megumi Kato-Itoh, Yuko Kamada, Ikue Shibasaki, Hyojung Jeon, Riko Kikuchi, Sayaka Wakayama and 4 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of reproduction and development, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Chloroquine inhibits artificial oocyte activation induced by ethanol or SrThe Journal of reproduction and development · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Kohei TorikaiFaculty of Life and Environmental Sciences, University of Yamanashi, Yamanashi 400-8510, Japan.
Kazuma ShimizuFaculty of Life and Environmental Sciences, University of Yamanashi, Yamanashi 400-8510, Japan.
Hiroaki NagatomoCenter for Life Science Research, University of Yamanashi, Yamanashi, 409-3898, Japan.
Mariko KasaiStem Cell Therapy Laboratory, Advanced Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Megumi Kato-ItohDivision of Stem Cell Therapy, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.
Yuko KamadaFaculty of Life and Environmental Sciences, University of Yamanashi, Yamanashi 400-8510, Japan.
Ikue ShibasakiFaculty of Life and Environmental Sciences, University of Yamanashi, Yamanashi 400-8510, Japan.
Hyojung JeonLaboratory of Stem Cell Therapy, Institute of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan.
Riko KikuchiLaboratory of Stem Cell Therapy, Institute of Medicine, University of Tsukuba, Ibaraki 305-8575, Japan.
Sayaka WakayamaAdvanced Biotechnology Center, University of Yamanashi, Yamanashi 400-8510, Japan.
Fabian SuchyInstitute for Stem Cell Biology and Regenerative Medicine, Department of Genetics, Stanford University School of Medicine, California 94305, USA.
Hiromitsu NakauchiStem Cell Therapy Laboratory, Advanced Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
Teruhiko WakayamaFaculty of Life and Environmental Sciences, University of Yamanashi, Yamanashi 400-8510, Japan.
Eiji MizutaniStem Cell Therapy Laboratory, Advanced Research Institute, Tokyo Medical and Dental University, Tokyo 113-8510, Japan.
University of Yamanashi · JPTokyo Medical and Dental University · JPUniversity of Tsukuba · JPStanford University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We examined various methods to enhance the accessibility of intracytoplasmic sperm injection (ICSI) technology to more users by making the technique easier, more efficient, and practical. First, the methods for artificially removing the mouse sperm tail were evaluated. Trypsin treatment was found to efficiently remove the sperm tails. The resultant sperm cells had a lower oocyte activation capacity; however, the use of activated oocytes resulted in the same fecundity as that of fresh, untreated sperm. Pre-activated oocytes were more resistant to physical damage, showed higher survival rates, and required less time per injection. Testing this method in rats yielded similar results, although the oocyte activation method was different. Remarkably, this method resulted in higher birth rates of rat progeny than with conventional methods of rat ICSI. Our method thereby streamlines mouse and rat ICSI, making it more accessible to laboratories across many disciplines.

Indexed as

Sperm Injections, IntracytoplasmicSperm TailAnimalsMaleMiceOocytesRatsSemenSpermatozoaTrypsinTrypsinIntracytoplasmic sperm injection (ICSI)MouseOocyte activationRatTrypsin treatment

Identifiers

PMID36529517
PMCPMC9939287
OpenAlexW4311934764

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.